| PRODUCTSSERVICESCOMPANYCONTACTFAQ |
|
Description: Pathological conditions involving ARTERIES in the skull, such as arteries supplying the CEREBRUM, the CEREBELLUM, the BRAIN STEM, and associated structures. They include atherosclerotic, congenital, traumatic, infectious, inflammatory, and other pathological processes.
Also Known As:| 1. | Stroke (Strokes)
|
| 2. | Pathologic Constriction (Stenosis)
|
| 3. | Embolism (Embolus)
|
| 1. | Moret, Jacques: 1 article (10/2005) |
| 2. | Mounayer, Charbel: 1 article (10/2005) |
| 3. | Vanzin, Jose Ricardo: 1 article (10/2005) |
| 4. | Piotin, Michel: 1 article (10/2005) |
| 5. | Spelle, Laurent: 1 article (10/2005) |
| 6. | Kessler, Iruena Moraes: 1 article (10/2005) |
| 1. | RNA (Ribonucleic Acid)IBA
09/01/1980
- "If intracranial arterial disease was excluded, the sensitivity of the studies was 92.1% for RNA and 84.2% for DS and combined evaluation had a sensitivity of 97.4%"
Order ALL the reference details at left... |
| 2. | SHU 508 (Levovist)IBA
03/01/2000
- "CONCLUSION: In stroke-age patients with limited acoustic windows, contrast-enhancement with Levovist can markedly increase the sensitivity of TCCD and increase the detection of clinically relevant intracranial arterial disease."
Order ALL the reference details at left... |
| 3. | TANDEMIBA
10/01/2002
- "PATIENTS: We enrolled 35 consecutive patients who had an acute ischemic stroke and (> or = 70%) stenosis or an occlusion of the extracranial ICA confirmed by cerebral angiography and an acute relevant stroke lesion on DWI within 1 week of onset, but without cardiac sources of embolism and tandem intracranial arterial disease"
Order ALL the reference details at left... |
CureHunter Patient-Physician Summary Reports collect in one document all the
medications ever reported in the US National Library of Medicine—1949 to the present—to
be effective against your target disease.
CureHunter research summary reports will vary in length from 25 to 250 pages.
Analytic charts allow you and your physicians to see at a glance your
medication options—including new, promising, off-label and experimental
all rated for clinical efficacy.
| Price: | $24.00
& Delivery via
PDF download
updates for 1 year |
| Price: | $490.00
access via web interface 1 year subscription |
| Price: | $45.00
access via "curehunter.com/m" 1 year subscription |